Skip to main content
Clinical Trials/NCT05322798
NCT05322798
Completed
Not Applicable

High-frequency Spinal Cord Stimulation in Treatment of Chronic Limb-Threatening Ischemia (HEAL-SCS): a Randomized Clinical Trial

Meshalkin Research Institute of Pathology of Circulation1 site in 1 country25 target enrollmentAugust 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Limb-Threatening Ischemia
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Enrollment
25
Locations
1
Primary Endpoint
Visual analog scale (VAS) score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study of high-frequency spinal cord stimulation (SCS) efficacy in the treatment of chronic limb-threatening ischemia (CLTI)

Detailed Description

Open-label, parallel-group, randomized study with a 1:1 allocation ratio to check the hypothesis of whether high-frequency-SCS (HF-SCS) is better than conventional low-frequency (LF-SCS) for pain relief in patients with chronic limb-threatening ischemia (CLTI).

Registry
clinicaltrials.gov
Start Date
August 12, 2018
End Date
May 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Meshalkin Research Institute of Pathology of Circulation
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • non-reconstructable critical limb-threatening ischemia (CLTI)
  • Fontaine stage IIB-IV
  • VAS score 5/10 or more
  • succesful SCS trial

Exclusion Criteria

  • intractable acute infection
  • allergy to SCS component
  • ulcerations larger than 3 cm2
  • inadequate patient compliance
  • life expectancy less than 12 months
  • patient refuse to participate in any stage of the study

Outcomes

Primary Outcomes

Visual analog scale (VAS) score

Time Frame: 12 months

score by visual analog scale (0-10)

Secondary Outcomes

  • TcPO2 (rest)(12 months)
  • Walking Impairment Questionnaire (WIQ) - walking distance(12 months)
  • Walking Impairment Questionnaire (WIQ) - walking speed(12 months)
  • SF-36 - mental component summary(12 months)
  • Visual analog scale (VAS) score(3 months)
  • Walking Impairment Questionnaire (WIQ) - calf pain severity(12 months)
  • Walking Impairment Questionnaire (WIQ) - stair climbing(12 months)
  • Short form 36 health survey (SF-36) - physical component summary(12 months)
  • TcPO2 (orthostatic probe)(12 months)

Study Sites (1)

Loading locations...

Similar Trials